There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Frustrated by past New Year's resolutions, columnist Desiree Lama is setting intentions to help redefine what progress with ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

The Cruel Intentions actress was first diagnosed with the autoimmune disease in 2018 and has been in remission since 2021.

The FDA rejected Sanofi's MS drug tolebrutinib, citing liver injury risks, unclear benefits, and trial data that failed to ...

Find out how combined chemical exposures and genetics may raise multiple sclerosis risk in new population research.

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...

The 54-year-old star recalled a phase when she had experienced MS flare-up, a moment she described that felt like her own ...